Profiles

Xin Feng

US FDA

Verified email at fda.hhs.gov

Cited by 2273

Regulatory Affairs CMC Pre-formulation Pharmaceutical Formulations Formulation Evaluation

Weikun Li

Amgen

Verified email at amgen.com

Cited by 1792

Pre-Formulation

Himanshu N. Bhatt

The University of Texas

Verified email at utep.edu

Cited by 913

Complex Generics Pre-formulation Drug delivery Pharmacokinetics

Wei Zhang

Senior Principal Scientist, Genentech Inc.

Verified email at gene.com

Cited by 802

Amorphous solid dispersion Pre-formulation Solid-state pharmaceutics Pharmaceutical formulation

Dev Prasad

Massachusetts College of Pharmacy and Health Sciences, Boston MA

Verified email at my.mcphs.edu

Cited by 581

Amorphous solid dispersion Oral and Parenteral formulation development Pre-formulation

Harsh S. Shah

Senior Scientist at Center for Pharma Crystallization (CfPC), J-Star Research Inc.

Verified email at my.liu.edu

Cited by 413

Formulation pre-formulation solid-state characterization

Ajay Saxena

Group Leader/Lead Investigator, Biocon-BMS Research and Development Center

Verified email at syngeneintl.com

Cited by 409

Pharmaceutics Pre-formulation Formulation Solid Dosage Form Development

Abhijeet Maurya

Amgen Inc.

Verified email at amgen.com

Cited by 375

Pharmaceutical Formulations Pre-formulation Amorphous solid dispersion Formulation Evaluation Regulatory Science

Kalpna Garkhal, PhD

Assistant Professor, NIPER-A

Verified email at niperahm.res.in

Cited by 352

Drug delivery Regenerative medicine Pre-formulation

Pratik Adhikary

Formulation Scientist

Verified email at mail.umkc.edu

Cited by 269

Polymorphism Pre-formulation Phage Display Peptide therapeutics BBB peptide drug delivery

1 - 10